Covaxin trial results for 2-18 age group pave way for inoculation of kids

Bharat Biotech said that Covaxin has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study.

Related Keywords

Mumbai ,Maharashtra ,India ,Hyderabad ,Andhra Pradesh ,United States ,Delhi ,United Kingdom ,America ,Bharat ,Zydus Cadila Zyco ,Vispi Jokhi ,Krishna Ella ,Union Health Ministry ,Bharat Biotech ,Managing Director ,Lav Agarwal ,Joint Secretary ,Union Health ,Zydus Cadila ,Covaxin ,Covid 19 Vaccine ,Ovid 19 News ,Harat Biotech Covaxnin ,Covaxin Study ,Tudy Covaxin Children ,Ovaxin 2 18 Year Olds ,Covaxin Trials ,Covaxin For Children ,Micron ,Micron News ,